Bayer CropScience Limited reported a net profit of ₹3,216 million for the quarter ended June 30, 2026, marking a 15.4% year-on-year increase from ₹2,787 million in Q1FY26. The profitability surge was primarily driven by an expansion in the EBITDA margin to 20.03% from 18.2% in the prior-year period, offsetting a 4.2% decline in revenue from operations to ₹18,350 million. This performance underscores the company’s ability to maintain earnings resilience through cost discipline and favorable product mix despite challenging market conditions.

The Board of Directors approved the unaudited financial results at a meeting held on August 5, 2026. The figures were subjected to limited review by statutory auditors Deloitte Haskins & Sells LLP. In compliance with Regulation 47 read with Schedule III Part A Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published the newspaper advertisement for its unaudited financial results on August 7, 2026, in Financial Express, Loksatta, Free Press Journal, and Navshakti. Bharati Ratan Shetty, Company Secretary and Compliance Officer, certified the submission to BSE Limited.

Financial Highlights

The following table summarises key financial metrics for the quarter alongside prior-year and full-year comparisons:

Total income remained relatively stable at ₹19,239 million compared to ₹19,333 million in Q1FY26. Other income rose sharply to ₹889 million from ₹187 million in the previous year’s quarter, largely due to a one-time gain of ₹639 million on the divestment of marketing rights for formulated products. Cost of materials consumed increased slightly to ₹10,427 million from ₹10,395 million, while employee benefits expense rose to ₹1,128 million from ₹1,043 million. Depreciation and amortisation expense increased significantly to ₹501 million from ₹272 million.

Management Commentary

Simon Wiebusch, Vice Chairman & Managing Director and CEO, Bayer CropScience Limited, stated, "We delivered a resilient start to FY2026-27, with our performance reflecting disciplined execution amid challenging weather and evolving market conditions." He noted that corn seeds sustained momentum despite an overall decline in acreage, supported by hybrid strength and focused customer engagement. Wiebusch highlighted that the company remains focused on proactive channel management and portfolio-led innovation as weather variability, including potential El Niño impacts, shapes the operating environment.

Vinit Jindal, Executive Director and Chief Financial Officer, added, "Profit After Tax increased by 15% during the quarter, supported by improved gross margins driven by favorable pricing actions and a stronger product mix." He noted that other operating expenses were higher compared with the corresponding quarter of the previous year and emphasized that improving working capital performance through inventory optimization and collections remains a key area of focus.

What the Numbers Show

The improvement in EBITDA margin to 20.03% from 18.2% year-on-year reflects better cost management and a favourable product mix, even as core operational revenue declined 4.2%. Total expenses decreased by a larger margin of 4.8%, improving pre-tax profit by nearly 20%. However, a significant portion of the bottom-line improvement stems from other income, which more than quadrupled year-on-year due to one-time gains from divestments, warranting closer scrutiny of recurring earnings drivers in subsequent quarters.

Bayer CropScience Ltd company name has appointed Ravi Kirpalani as Additional Independent Director and Chairman of the Board, effective September 12, 2026. The appointment succeeds Pankaj Patel, who completes his second consecutive term as Chairman and Non-Executive Independent Director at the close of business hours on September 11, 2026. This leadership transition ensures continuity in governance as Patel steps down from his roles in the Audit Committee, Corporate Social Responsibility & Environmental, Social and Governance Committee, and the Stakeholders' Relationship Committee.

The Board of Directors approved the changes during a meeting held on August 05, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kirpalani’s appointment as an Additional Independent Director is effective from September 01, 2026, for a term of five consecutive years ending August 31, 2031. This directorship is subject to shareholder approval. His assumption of the Chairman role is scheduled for the day immediately following Patel’s tenure expiry.

Kirpalani brings over four decades of experience in sales, marketing, strategy, and corporate leadership across multinational organizations. His professional background includes serving as Managing Director and CEO of Thyssenkrupp India Pvt. Ltd. from March 2016 to March 2021, where he oversaw a portfolio employing more than 6,000 people. Prior to that, he was Managing Director of Castrol India Ltd. from May 2009 to February 2016, part of a 16-year tenure with BP/Castrol that included a role as Global Strategy Director for the lubricants business.

Board Appointments and Tenure

Kirpalani’s broader board experience includes serving as Independent Director and Chairman of Foseco India Ltd. since 2018. He joined the Board of Greaves Cotton Limited in May 2021, specifically following its acquisition of Excel Controlinkage Pvt. Ltd., and added Versuni India Home Solutions Ltd. (formerly Philips Domestic Appliances India Ltd.) to his portfolio in October 2025. He also serves on the boards of the Indo-German Chamber of Commerce and the Bombay Chamber of Commerce and Industry.

Governance Compliance

The Nomination and Remuneration Committee recommended Kirpalani’s appointment. The filing confirms that Kirpalani is not related to any existing directors under Section 2(77) of the Companies Act, 2013, nor is he debarred from holding office by any SEBI order or statutory authority. The disclosure aligns with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023, and relevant BSE and NSE circulars regarding director appointments.

What the Numbers Show

The staggered effective dates highlight a precise governance handover. Kirpalani joins the board as an independent director on September 1, 2026, providing a ten-day transition period before assuming the Chairman role on September 12, 2026. This structure allows for immediate integration into board dynamics before taking on the chairmanship responsibilities, ensuring no gap in leadership oversight between Patel’s departure and Kirpalani’s accession.